Skip to main content


DaVita bounces after President Trump signs executive order on kidney disease

By MarketWatch  
   July 10, 2019

Shares of DaVita Inc. bounced 4.3% in afternoon trading Wednesday, after President Trump signed an executive order on kidney disease, aimed at cutting costs of dialysis treatments. The stock had tumbled 9.8% over the past two sessions in anticipation of the executive order.

Full story

Get the latest on healthcare leadership in your inbox.